Added value and clinical impact of second-opinion subspecialist radiologist interpretations of baseline rectal MRI in patients with rectal cancer
Jennifer S. Golia Pernicka(Memorial Sloan Kettering Cancer Center), Marc J. Gollub(Memorial Sloan Kettering Cancer Center), Stéphanie Nougaret(Inserm), James L. Fuqua(Memorial Sloan Kettering Cancer Center), Maria Widmar(Memorial Sloan Kettering Cancer Center), Iva Petkovska(Beth Israel Deaconess Medical Center), Natally Horvat(Alliance Data (United States)), Natalie Gangai(Memorial Sloan Kettering Cancer Center), Viktoriya Paroder(Memorial Sloan Kettering Cancer Center), Maria El Homsi(Memorial Sloan Kettering Cancer Center), Emmanouil Pappou(Memorial Sloan Kettering Cancer Center), Tae‐Hyung Kim(Hanyang University), David D. B. Bates(Memorial Sloan Kettering Cancer Center)
Cited by 1
Related Papers
Preoperative Treatment of Locally Advanced Rectal Cancer
|New England Journal of Medicine|2023|440
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
|Nature Reviews Clinical Oncology|2020|365
O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee
|Radiology|2022|196
Society of Abdominal Radiology (SAR) and European Society of Urogenital Radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders
|European Radiology|2020|172
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)
|Journal of Clinical Oncology|2023|136